Director Shareholding

AstraZeneca PLC 21 February 2002 DEALING BY DIRECTORS COMPANIES ACT 1985 SECTION 324/329 WE HEREBY INFORM YOU THAT, ON 19 FEBRUARY 2002, WE WERE NOTIFIED BY MR A B T STAVLING, A DIRECTOR OF THE COMPANY, THAT, ON 15 FEBRUARY 2002, HE SOLD OPTIONS OVER ASTRAZENECA PLC ORDINARY SHARES OF USD0.25 EACH AS FOLLOWS:- NUMBER OF OPTIONS SOLD SALE PRICE PER OPTION DATE OF SALE 2,717 318.18SEK 15.02.02 3,267 306.14SEK 15.02.02 THESE OPTIONS WERE ORIGINALLY GRANTED TO MR STAVLING OVER SHARES IN ASTRA AB UNDER THE ASTRA SHAREHOLDER VALUE INCENTIVE PLAN AND WERE CONVERTED INTO OPTIONS OVER ORDINARY SHARES IN ASTRAZENECA PLC IN APRIL 1999. DETAILS OF THE UNDERLYING ASTRAZENECA SHARES OVER WHICH THE OPTIONS WERE HELD ARE AS FOLLOWS:- NUMBER OF ASTRAZENECA EFFECTIVE OPTION CLOSING PRICE OF ASTRAZENECA SHARES OVER WHICH PRICE PER SHARE SHARES ON DATE OPTIONS OPTIONS WERE HELD WERE SOLD 3,655 298.28SEK 533SEK 4,395 316.13SEK 533SEK FOLLOWING THESE TRANSACTIONS, MR STAVLING HOLDS OPTIONS OVER 92,340 ORDINARY SHARES OF ASTRAZENECA PLC. G H R MUSKER COMPANY SECRETARY 21 FEBRUARY 2002 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100